openPR Logo
Press release

Ursodeoxycholic Acid Market – Assessment On Product Benefits 2028 | Abil Chempharma, Daewoong Chemical

02-05-2019 01:11 PM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
Ursodeoxycholic Acid Market – Assessment On Product Benefits 2028 | Abil Chempharma, Daewoong Chemical

Global Ursodeoxycholic Acid Market: Overview

Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. This increases the amount of nontoxic hydrophilic bile acids. Besides, UDCA can slow down the development of gastroesophageal varices and progression to cirrhosis. Further, it can also better chances of survival of patients.

Request Sample Copy of the Report @
www.tmrresearch.com/sample/sample?flag=B&rep_id=4221

It is said that substantial betterment of liver health can be achieved with UDCA therapy in people afflicted with primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, nonalcoholic fatty liver disease, total parenteral nutrition-induced cholestasis, cystic fibrosis-associated liver disease, graft related liver disease, and in certain cholestatic liver condition in children.

Global Ursodeoxycholic Acid Market: Drivers and Restraints

Cholestatic liver diseases are at the forefront of driving demand in the global ursodeoxycholic acid market. Rising instances of gall stones and cystic fibrosis is in large part responsible for driving the market. As per 2015 data released by Cystic Fibrosis Foundation, about 30,000 people are afflicted with cystic fibrosis in the U.S. alone.

Request TOC of the Report @
www.tmrresearch.com/sample/sample?flag=T&rep_id=4221

Women are highly prone to having gallstones when compared to men. This is mainly because of the high levels of estrogen during pregnancy, hormone replacement therapy, and usage of birth control pills. Further, older adults are also highly susceptible to gallstones along with those having a family history of gallstones. While surgery is the most widespread treatment for it, ursodeoxycholic acid can dissolve smaller stones formed mostly of cholesterol. This is having a positive impact on the market.

Certain side effects of UDCA, on the other hand, are preventing the ursodeoxycholic acid market from achieving its full potential. For instance, treatment with UDCA often leads to diarrhea. As per a study by the National Center for Biotechnology Information (NCBI) published in 2017, the incidence of diarrhea in patients with gallstone being treated with UCDA is almost 2 to 9%. Besides, the treatment also leads to side effects such as vomiting, nausea, dry skin or itching, sleep disturbance, and headache. Cause of such side effects, it cannot be administered in the first trimester of pregnancy.

Global Ursodeoxycholic Acid Market: Trends and Opportunities

The two types of ursodeoxycholic acid available in the market are extraction ursodeoxycholic acid and synthetic ursodeoxycholic acid. Of the two, the synthetic ursodeoxycholic acid is more substantial. Ursodeoxycholic acid finds usage in health products and pharmacy. Between the two, the health products generate most of the demand.

Global Ursodeoxycholic Acid Market: Regional Analysis

With respect to geography, Europe at present rakes in maximum revenue in the global ursodeoxycholic acid market. This is primarily on the back of rising support of the government for liver diseases. Europe is not just the largest supplier of the product but also the largest consumer. North America ursodeoxycholic acid market is another prominent one because of the same reason. Surge in cases of cystic fibrosis is also having a positive impact on the market.

Read Comprehensive Overview of Report @
www.tmrresearch.com/ursodeoxycholic-acid-market

Global Ursodeoxycholic Acid Market: Competitive Landscape

Some of the prominent participants in the global ursodeoxycholic acid market are Arcelor Chemicals, Abil Chempharma, Daewoong Chemical, Biotavia Labs, and Dipharma Francis. Market competition is intense. The overall ursodeoxycholic acid market is highly competitive and with consumer awareness will grow in future.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ursodeoxycholic Acid Market – Assessment On Product Benefits 2028 | Abil Chempharma, Daewoong Chemical here

News-ID: 1561136 • Views: 147

More Releases from TMR Research

Healthcare Regulatory Affairs Outsourcing Market - Overview On Upcoming Need 202 …
Global Healthcare Regulatory Affairs Outsourcing Market: Snapshot The healthcare regulatory affairs outsourcing market is experiencing significant growth owing to services to Clinical Research Organizations. The rising number of patent expirations along with growing costs of research and development activities are the primary factors influencing the growth of the global healthcare regulatory affairs outsourcing market. Healthcare and biopharmaceutical organizations are likely to team up with numerous outsourcing companies for getting their drugs
Physician Office Laboratory (POL) Market - Current Opportunities 2025 | Accriva …
Global Physician Office Laboratory (POL) Market: Snapshot The global Physician Office Laboratory (POL) Market has been expanding substantially over the last few years. Supported by the technological advancements, the market is likely to remain proliferating over the next few years. POL testing has its base in developed regions as emerging economies still rely on hospital infrastructure for the diagnosis of acute and chronic medical conditions. Developing regions, however, has been demonstrating
Urological Catheters Market - Insights On Scope 2025 | Bard Medical, Rochester M …
Global Urological Catheters Market: Snapshot Catheters are medical instruments that are commonly used when a patient is unable to empty his or her bladder. If urine is allowed to build up in the patient’s bladder for a long time, the rising pressure in the kidneys can lead to kidney failure. The elderly people and patients with severe illness or injuries might need to use catheters for longer periods of time than
Tinnitus Market - Comprehensive Survey On Demand 2025 | Auris Medical Holding AG …
Global Tinnitus Market: Snapshot The global tinnitus market exhibited impressive growth in the recent past as the number of people suffering from tinnitus has been increasingly continuously. Tinnitus is a physical condition that occurs within an ear when there is no external noise mainly considered as a hearing perception. In most of the cases tinnitus occurs due to fluctuation in cochlea’s nerve activity as the auditory inputs are reduced. There are

All 25863 Releases


More Releases for Ursodeoxycholic Acid UDCA

Global Ursodeoxycholic Acid Industry Market Analysis & Forecast 2018-2023
Global Ursodeoxycholic Acid Industry has been utilized in the administration of puppies with incessant hepatitis and felines with lymphocytic plasmacytic cholangitis. It is accepted to be most useful in scatters where bile poisonous quality assumes an imperative job in the continuous pathology. The adequacy of Global Ursodeoxycholic Acid Industry in veterinary patients has not been certainly settled, in spite of the fact that reports recommend it might have some advantage
Ursodeoxycholic Acid Market 2017-ICE, Grindeks, Mitsubishi Tanabe, Daewoong chem …
Apex Market Reports, recently published a detailed market research study focused on the "Ursodeoxycholic Acid Market" across the global, regional and country level. The report provides 360° analysis of "Ursodeoxycholic Acid Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Ursodeoxycholic Acid industry, and estimates the future trend of Ursodeoxycholic Acid market
Ursodeoxycholic Acid Market 2017 Forecast to 2022
"Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis." Read Detailed Full Report @ https://www.reportsandmarkets.com/reports/global-north-america-europe-and-asia-to-2022-1686998 Scope of the Report: Ursodeoxycholic Acid in Global market, especially in North
Ursodeoxycholic Acid Market- ICE, Grindeks, Mitsubishi, Daewoong chemical, Pharm …
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number